Followers | 1078 |
Posts | 80316 |
Boards Moderated | 8 |
Alias Born | 03/10/2009 |
Thursday, August 06, 2020 3:13:23 PM
operations since its inception.
30, 2020
The Information (i) constitutes “adequate current public information” concerning the Securities and the Company and
“is available” within the meaning of Rule 144(c)(2) under the Securities Act, (ii) includes all of the information that a
broker-dealer would be required to obtain from the Company to publish a quotation for the Securities under Rule 15c2-
11 under the Securities Exchange Act of 1934 (the “Exchange Act”), (iii) complies as to form with the OTC Market’s
Guidelines for Providing Adequate Current Information, which are located on the Internet at www.otcmarkets.com,
and (iv) has been posted through the OTC Disclosure and News Service.
The financial statements are unaudited. The person responsible for the preparation of the Company’s financial
statements contained in the Information is Anthony Coleman, Certified Public Accountant, who issued a compilation
report on such financial statements. The Company’s transfer agent is Direct Transfer, LLC, a subsidiary of Issuer
Direct Corporation, and is duly registered with the SEC. I reviewed a statement provided by the transfer agent to
confirm the number of outstanding shares set forth in the Information. I have personally met with management and a
majority of the directors of Twin Vee Powercats, Inc., specifically, Joseph C. Visconti and Preston Yarborough, (ii)
reviewed the Information published by the Company through the OTC Disclosure and News Service and (iii) discussed
the Information with management and a majority of the directors of the Company. I am not currently under
investigation by any federal or state regulatory authority for any violation of federal or states securities laws, and to the
best of my knowledge after inquiry of management and the directors of the Company, neither of the Company, nor any
5% equity holder of the Company is under such investigation. No person other than OTC Markets is entitled to rely on
this letter. I grant OTC Markets full and complete permission and rights to publish this letter through the OTC
Disclosure and News Service for viewing by the public and regulators.
Twin Vee Powercats, Inc., nor its predecessors, is not and have never been a shell company as defined in Rules 405 of
the Securities Act of 1933 and 12b-2 of the Exchange Act of 1934. Twin Vee Powercats, Inc. has always had active
operations since its inception.
Very truly yours,
Glenn Sonoda, ESQ.
https://backend.otcmarkets.com/otcapi/company/financial-report/245522/content
STOP & VISIT MY BOARD AT: HOTTEST PENNY STOCK PICKS
http://investorshub.advfn.com/boards/board.aspx?board_id=19627
My posts are NOT a buy/sell recommendation, Do your Own DD, before you buy any stock - I reserve the right to buy/sell any stock
Recent VEEE News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/08/2024 09:00:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2024 02:32:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 10:20:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2023 03:19:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/13/2023 08:10:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 08:00:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/06/2023 08:52:56 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 08/31/2023 08:05:55 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 08/31/2023 08:05:25 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 08/28/2023 08:31:47 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/28/2023 08:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2023 08:10:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:05:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 12:15:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2023 08:15:56 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM